Profile photo.

Imogene M Dunn

Reviewer, Section Editor

Biostatistics Immunovant

United States


Dr. Imogene Dunn is currently the Vice President of Biostatistics at Immunovant, Inc. Her distinguished career has focused on biostatistics, data management and regulatory science leadership for over two decades in the in the therapeutic development industry in organizations including vTv Therapeutics (formerly TransTech Pharma), CATO Research, GSK, Pfizer, and Regeneron. Imogene was a founding author of the Good Clinical Data Management Practices (GCDMP) for which she authored the Safety Data Management chapter. Dr. Dunn has continued to support SCDM through serving as an item writer for the international Certified Clinical Data Manager (CCDMTM) exam and as an author of the GCDMP Measuring Data Quality chapter currently in revision. She has authored multiple articles in the statistical and therapeutic development literature. Imogene Dunn holds a PhD in Biostatistics from the University of North Carolina at Chapel Hill. Through an innovative program sponsored through the Public Health Service, her doctoral training included clinical data management. Dr. Dunn also holds a doctoral minor in epidemiology.